Blood analyses and survival in symptom‐ and survey‐detected lung cancer patients

Abstract. Commonly recorded blood analyses as indicators of low‐ and‐high risk patients with lung cancer were studied by comparing symptom‐ and survey‐detected patients. During the period 1976–1985, in 41 of 189 non‐small‐cell lung cancer patients in Western Norway, lung cancer was detected by chest X‐ray survey performed in the preventive tuberculosis screening programme. After adjusting for other variables, including developmental stage, erythrocyte sedimentation rate (ESR) was the only blood analysis which discriminated symptom‐detected patients (high ESR) from survey‐detected patients (low ESR). Survey‐detected patients had a better short‐term survival. In multivariate survival analyses leucocyte count, lactate dehydrogenase activity and ESR were significant prognostic factors, in addition to advanced stage and detection due to symptoms. We conclude that common blood analyses such as ESR provide supplementary information concerning low‐and high‐risk lung cancer patients.

[1]  E. Hannisdal,et al.  Blood analyses as prognostic factors in primary lung cancer. , 1990, Acta oncologica.

[2]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[3]  L. Bostad,et al.  Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  M. Tubiana,et al.  Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  K. Ebeling,et al.  Screening for lung cancer‐results from a case‐control study , 1987, International journal of cancer.

[6]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[7]  K. Maclennan,et al.  REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX , 1985, The Lancet.

[8]  T. Gislason,et al.  Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study. , 1985, European journal of respiratory diseases.

[9]  W F Taylor,et al.  Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. , 2015, The American review of respiratory disease.

[10]  B J Flehinger,et al.  Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. , 2015, The American review of respiratory disease.

[11]  W. C. Ball,et al.  Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. , 2015, The American review of respiratory disease.

[12]  M. Tubiana,et al.  Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Early lung cancer detection: summary and conclusions. , 1984, The American review of respiratory disease.

[14]  A. Miller,et al.  Simple rule for calculating normal erythrocyte sedimentation rate. , 1983, British medical journal.

[15]  W. Hop,et al.  Prognostic indexes for renal cell carcinoma. , 1980, European journal of cancer.

[16]  S. Lewis,et al.  Recommendation for Measurement of Erythrocyte Sedimentation Rate of Human Blood: International Committee For Standardization in Haematology , 1977 .

[17]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[18]  N. Tryding,et al.  Recommended methods for the determination of four enzymes in blood. , 1974, Scandinavian journal of clinical and laboratory investigation.

[19]  K. Bjartveit.  Mass miniature radiography in Norway, today and in the future. , 1972, Scandinavian journal of respiratory diseases. Supplementum.

[20]  L. Böttiger.  Prognosis in renal carcinoma , 1970, Cancer.

[21]  G. J. Cunningham,et al.  VENTILATION OF OPERATING-THEATRES. , 1964, Lancet.

[22]  H. Höst.  The value of periodic mass chest roentgenographic surveys in the detection of primary bronchial carcinoma in Norway , 1960 .

[23]  H. Høst.  The value of periodic mass chest roentgenographic surveys in the detection of primary bronchial carcinoma in Norway. , 1960, Cancer.

[24]  K. W. Cross,et al.  Mass Radiography and Cancer of the Lung , 1959, British medical journal.

[25]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.

[26]  A. Scheel.  [The Norwegian radium hospital]. , 1951, Nordisk Medicin.

[27]  D.,et al.  Regression Models and Life-Tables , 2022 .